Summary

The global coronary stents market remains a critical component of cardiovascular care, addressing the growing burden of coronary artery disease across the world. Coronary stents are essential medical devices used in angioplasty procedures to open blocked arteries and restore blood flow, thereby reducing the risk of heart attacks and improving patient outcomes. With cardiovascular diseases continuing to rank among the leading causes of mortality globally, the demand for advanced interventional solutions is steadily increasing. The market is projected to reach USD 8.4 billion in 2026 and is anticipated to grow to USD 11.3 billion by 2033, expanding at a compound annual growth rate of 4.30% during the forecast period. Continuous technological innovation and expanding access to cardiac care are shaping the market landscape.

Market Insights

The coronary stents market has evolved significantly, driven by the transition from traditional bare metal stents to more advanced alternatives such as drug-eluting and bioresorbable stents. Drug-eluting stents currently lead the market due to their ability to release medication that prevents arterial re-narrowing, offering better long-term results compared to earlier technologies. At the same time, bioresorbable stents are gaining momentum as they gradually dissolve in the body, eliminating the long-term presence of foreign material and reducing complications.

The growing adoption of minimally invasive procedures is further accelerating market growth. Angioplasty procedures using stents are widely preferred due to their efficiency, shorter recovery times, and reduced risk compared to open-heart surgeries. In addition, improvements in stent materials and design, including enhanced flexibility and biocompatibility, are increasing procedural success rates and patient safety.

Drivers

A major factor driving the coronary stents market is the increasing prevalence of cardiovascular diseases worldwide. Changing lifestyles, including poor dietary habits, physical inactivity, and rising stress levels, are contributing to a surge in heart-related conditions. This has significantly increased the demand for effective treatment options such as coronary stents.

Technological advancements in stent development also play a crucial role in market expansion. Innovations such as thinner strut designs, advanced drug coatings, and improved delivery systems are enhancing the effectiveness of stents while minimizing complications. These developments are encouraging healthcare providers to adopt newer technologies.

In addition, growing healthcare investments and improved access to medical facilities, particularly in developing regions, are supporting the wider adoption of coronary stenting procedures. Increased awareness regarding early diagnosis and treatment of heart diseases is further strengthening market growth.

Business Opportunity

The coronary stents market offers promising opportunities for growth, especially in emerging economies. Rapid urbanization, improving healthcare infrastructure, and rising disposable incomes in regions such as Asia Pacific and Latin America are creating favorable conditions for market expansion.

Opportunities also lie in the development of next-generation stents that focus on enhanced safety and long-term effectiveness. Innovations such as bioresorbable scaffolds and polymer-free drug-eluting stents are expected to redefine treatment approaches and open new avenues for manufacturers.

Strategic partnerships, product launches, and geographic expansion are likely to remain key growth strategies for companies aiming to strengthen their market presence. Investment in research and development will continue to be essential for staying competitive in this evolving market.

Region Analysis

North America dominates the coronary stents market due to its advanced healthcare infrastructure, high healthcare spending, and strong presence of leading medical device manufacturers. The region also benefits from early adoption of innovative technologies and favorable reimbursement frameworks.

Europe holds a significant share, supported by a growing aging population and increasing incidence of cardiovascular diseases. Countries such as Germany, the United Kingdom, and France are major contributors to regional growth.

Asia Pacific is expected to experience the fastest growth during the forecast period. A large patient population, increasing awareness about cardiovascular health, and improving access to healthcare services are driving demand in the region. Emerging economies like China and India are witnessing rapid adoption of advanced cardiac treatments.

Latin America and the Middle East and Africa are gradually expanding, supported by ongoing improvements in healthcare infrastructure and rising awareness about modern treatment options.

Key Players

• Medtronic

• Abbott

• Boston Scientific Corporation

• B Braun Melsungen AG

• Terumo Corporation

• MicroPort Scientific Corporation

• Biotronik

• R. Bard, Inc.

• Stentys SA

• Cook Medical

Segmentation

By Product Type:

• Drug-Eluting Stent

• Bare Metal Stent

• Bioresorbable stent

By Raw Material Type:

• Cobalt Chromium

• Stainless Steel

• Platinum Chromium

• Polymer

By End User:

• Hospitals

• Ambulatory Surgical Centres

• Cardiac Catheterization Laboratories

By Geographic Coverage:

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Coronary Stents Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Coronary Stents Market Outlook, 2020-2033
3.1. Global Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.1.1. Drug-Eluting Stent
3.1.2. Bare Metal Stent
3.1.3. Bioresorbable stent
3.2. Global Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
3.2.1. Cobalt Chromium
3.2.2. Stainless Steel
3.2.3. Platinum Chromium
3.2.4. Polymer
3.3. Global Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.3.1. Hospitals
3.3.2. Ambulatory Surgical Centres
3.3.3. Cardiac Catheterization Laboratories
3.4. Global Coronary Stents Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Coronary Stents Market Outlook, 2020-2033
4.1. North America Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.1.1. Drug-Eluting Stent
4.1.2. Bare Metal Stent
4.1.3. Bioresorbable stent
4.2. North America Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
4.2.1. Cobalt Chromium
4.2.2. Stainless Steel
4.2.3. Platinum Chromium
4.2.4. Polymer
4.3. North America Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.3.1. Hospitals
4.3.2. Ambulatory Surgical Centres
4.3.3. Cardiac Catheterization Laboratories
4.4. North America Coronary Stents Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Coronary Stents Market Outlook, by Product Type, 2020-2033
4.4.2. U.S. Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
4.4.3. U.S. Coronary Stents Market Outlook, by End User, 2020-2033
4.4.4. Canada Coronary Stents Market Outlook, by Product Type, 2020-2033
4.4.5. Canada Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
4.4.6. Canada Coronary Stents Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Coronary Stents Market Outlook, 2020-2033
5.1. Europe Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.1.1. Drug-Eluting Stent
5.1.2. Bare Metal Stent
5.1.3. Bioresorbable stent
5.2. Europe Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
5.2.1. Cobalt Chromium
5.2.2. Stainless Steel
5.2.3. Platinum Chromium
5.2.4. Polymer
5.3. Europe Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.3.1. Hospitals
5.3.2. Ambulatory Surgical Centres
5.3.3. Cardiac Catheterization Laboratories
5.4. Europe Coronary Stents Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.2. Germany Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.3. Germany Coronary Stents Market Outlook, by End User, 2020-2033
5.4.4. Italy Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.5. Italy Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.6. Italy Coronary Stents Market Outlook, by End User, 2020-2033
5.4.7. France Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.8. France Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.9. France Coronary Stents Market Outlook, by End User, 2020-2033
5.4.10. U.K. Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.11. U.K. Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.12. U.K. Coronary Stents Market Outlook, by End User, 2020-2033
5.4.13. Spain Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.14. Spain Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.15. Spain Coronary Stents Market Outlook, by End User, 2020-2033
5.4.16. Russia Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.17. Russia Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.18. Russia Coronary Stents Market Outlook, by End User, 2020-2033
5.4.19. Rest of Europe Coronary Stents Market Outlook, by Product Type, 2020-2033
5.4.20. Rest of Europe Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
5.4.21. Rest of Europe Coronary Stents Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Coronary Stents Market Outlook, 2020-2033
6.1. Asia Pacific Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.1.1. Drug-Eluting Stent
6.1.2. Bare Metal Stent
6.1.3. Bioresorbable stent
6.2. Asia Pacific Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
6.2.1. Cobalt Chromium
6.2.2. Stainless Steel
6.2.3. Platinum Chromium
6.2.4. Polymer
6.3. Asia Pacific Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centres
6.3.3. Cardiac Catheterization Laboratories
6.4. Asia Pacific Coronary Stents Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.2. China Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.3. China Coronary Stents Market Outlook, by End User, 2020-2033
6.4.4. Japan Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.5. Japan Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.6. Japan Coronary Stents Market Outlook, by End User, 2020-2033
6.4.7. South Korea Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.8. South Korea Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.9. South Korea Coronary Stents Market Outlook, by End User, 2020-2033
6.4.10. India Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.11. India Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.12. India Coronary Stents Market Outlook, by End User, 2020-2033
6.4.13. Southeast Asia Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.14. Southeast Asia Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.15. Southeast Asia Coronary Stents Market Outlook, by End User, 2020-2033
6.4.16. Rest of SAO Coronary Stents Market Outlook, by Product Type, 2020-2033
6.4.17. Rest of SAO Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
6.4.18. Rest of SAO Coronary Stents Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Coronary Stents Market Outlook, 2020-2033
7.1. Latin America Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.1.1. Drug-Eluting Stent
7.1.2. Bare Metal Stent
7.1.3. Bioresorbable stent
7.2. Latin America Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
7.2.1. Cobalt Chromium
7.2.2. Stainless Steel
7.2.3. Platinum Chromium
7.2.4. Polymer
7.3. Latin America Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centres
7.3.3. Cardiac Catheterization Laboratories
7.4. Latin America Coronary Stents Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Coronary Stents Market Outlook, by Product Type, 2020-2033
7.4.2. Brazil Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
7.4.3. Brazil Coronary Stents Market Outlook, by End User, 2020-2033
7.4.4. Mexico Coronary Stents Market Outlook, by Product Type, 2020-2033
7.4.5. Mexico Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
7.4.6. Mexico Coronary Stents Market Outlook, by End User, 2020-2033
7.4.7. Argentina Coronary Stents Market Outlook, by Product Type, 2020-2033
7.4.8. Argentina Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
7.4.9. Argentina Coronary Stents Market Outlook, by End User, 2020-2033
7.4.10. Rest of LATAM Coronary Stents Market Outlook, by Product Type, 2020-2033
7.4.11. Rest of LATAM Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
7.4.12. Rest of LATAM Coronary Stents Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Coronary Stents Market Outlook, 2020-2033
8.1. Middle East & Africa Coronary Stents Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.1.1. Drug-Eluting Stent
8.1.2. Bare Metal Stent
8.1.3. Bioresorbable stent
8.2. Middle East & Africa Coronary Stents Market Outlook, by Raw Material Type, Value (US$ Bn), 2020-2033
8.2.1. Cobalt Chromium
8.2.2. Stainless Steel
8.2.3. Platinum Chromium
8.2.4. Polymer
8.3. Middle East & Africa Coronary Stents Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centres
8.3.3. Cardiac Catheterization Laboratories
8.4. Middle East & Africa Coronary Stents Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Coronary Stents Market Outlook, by Product Type, 2020-2033
8.4.2. GCC Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
8.4.3. GCC Coronary Stents Market Outlook, by End User, 2020-2033
8.4.4. South Africa Coronary Stents Market Outlook, by Product Type, 2020-2033
8.4.5. South Africa Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
8.4.6. South Africa Coronary Stents Market Outlook, by End User, 2020-2033
8.4.7. Egypt Coronary Stents Market Outlook, by Product Type, 2020-2033
8.4.8. Egypt Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
8.4.9. Egypt Coronary Stents Market Outlook, by End User, 2020-2033
8.4.10. Nigeria Coronary Stents Market Outlook, by Product Type, 2020-2033
8.4.11. Nigeria Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
8.4.12. Nigeria Coronary Stents Market Outlook, by End User, 2020-2033
8.4.13. Rest of Middle East Coronary Stents Market Outlook, by Product Type, 2020-2033
8.4.14. Rest of Middle East Coronary Stents Market Outlook, by Raw Material Type, 2020-2033
8.4.15. Rest of Middle East Coronary Stents Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Abbott
9.4.3. Boston Scientific Corporation
9.4.4. B Braun Melsungen AG
9.4.5. Terumo Corporation
9.4.6. MicroPort Scientific Corporation
9.4.7. Biotronik
9.4.8. R. Bard, Inc.
9.4.9. Stentys SA
9.4.10. Cook Medical
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations